Mark Frattini
Company: Cellectis
Job title: Chief Medical Officer
Seminars:
Showcasing Safety & Clinical Activity of Next Generation Allogeneic Product to Overcome Patient Relapse 10:00 am
day: Day Two
Industry Leader’s Fireside Chat – Exploring the Past, Present & Future of Allogeneic Cell Therapies 9:00 am
An executive panel discussion from the industry leaders of the field to set the scene on the allogeneic cell therapy space. Ask your questions live to understand the expert’s thoughts on key topics including: The evolving shift in the cell therapy field from autologous to allogeneic Next generation and complex gene editing and the safety…Read more
day: Day One